Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × Valacyclovir × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 37 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Radiation 6 Irinotecan 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Flucytosine 5 Filgrastim 5 Carmustine 5 O(6)-benzylguanine 4 Imiquimod 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Erlotinib Hydrochloride 4 Craniotomy 4 Aminolevulinic Acid 4 vocimagene amiretrorepvec 3 vandetanib 3 sargramostim 3 Topotecan 3 Thiotepa 3 Standard of Care 3 Radiotherapy, Intensity-Modulated 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00751270 2023-08-25

BrTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Astrocytoma, Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡